(Q38129728)

English

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies

scientific article published on 18 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies (English)

1 reference

Europe PubMed Central

29 August 2017

Behçet's disease

13 references

12 March 2019

13 March 2019

21 March 2019

22 April 2019

25 April 2019

17 June 2019

1 August 2019

27 September 2019

3 October 2019

20 November 2019

27 November 2019

13 December 2019

12 November 2020

intestinal disease

13 references

12 March 2019

13 March 2019

21 March 2019

22 April 2019

25 April 2019

17 June 2019

1 August 2019

27 September 2019

3 October 2019

20 November 2019

27 November 2019

13 December 2019

12 November 2020

monoclonal antibody

1 reference

based on heuristic

inferred from title

15

object named as

Toshifumi Hibi

1 reference

Europe PubMed Central

29 August 2017

Takayuki Matsumoto

3

object named as

Takayuki Matsumoto

1 reference

Europe PubMed Central

29 August 2017

author name string

Tadakazu Hisamatsu

1

1 reference

Europe PubMed Central

29 August 2017

Fumiaki Ueno

2

1 reference

Europe PubMed Central

29 August 2017

Kiyonori Kobayashi

4

1 reference

Europe PubMed Central

29 August 2017

Kazutaka Koganei

5

1 reference

Europe PubMed Central

29 August 2017

Reiko Kunisaki

6

1 reference

Europe PubMed Central

29 August 2017

Fumihito Hirai

7

1 reference

Europe PubMed Central

29 August 2017

Masakazu Nagahori

8

1 reference

Europe PubMed Central

29 August 2017

Mitsunobu Matsushita

9

1 reference

Europe PubMed Central

29 August 2017

Kenji Kobayashi

10

1 reference

Europe PubMed Central

29 August 2017

Mitsumasa Kishimoto

11

1 reference

Europe PubMed Central

29 August 2017

Mitsuhiro Takeno

12

1 reference

Europe PubMed Central

29 August 2017

Masanori Tanaka

13

1 reference

Europe PubMed Central

29 August 2017

Nagamu Inoue

14

1 reference

Europe PubMed Central

29 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 August 2013

1 reference

Europe PubMed Central

29 August 2017

1 January 2014

15 references

12 March 2019

13 March 2019

21 March 2019

22 April 2019

25 April 2019

17 June 2019

1 August 2019

27 September 2019

3 October 2019

20 November 2019

27 November 2019

13 December 2019

12 November 2020

1 February 2021

28 October 2022

Journal of Gastroenterology

16 references

Europe PubMed Central

29 August 2017

12 March 2019

13 March 2019

21 March 2019

22 April 2019

25 April 2019

17 June 2019

1 August 2019

27 September 2019

3 October 2019

20 November 2019

27 November 2019

13 December 2019

12 November 2020

1 February 2021

28 October 2022

49

1 reference

Europe PubMed Central

29 August 2017

1

1 reference

Europe PubMed Central

29 August 2017

156-162

1 reference

Europe PubMed Central

29 August 2017

copyright license

Creative Commons Attribution-NonCommercial 2.5 Generic

1 reference

Europe PubMed Central

28 October 2022

Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

6 September 2017

Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

6 September 2017

Behçet's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

6 September 2017

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

23 June 2018

Clinical course of intestinal Behcet's disease during the first five years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

31 August 2018

A case of intestinal Behçet's disease treated with infliximab monotherapy who successfully maintained clinical remission and complete mucosal healing for six years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

31 August 2018

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

31 August 2018

Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

31 August 2018

Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

31 August 2018

Infliximab as an alternative treatment for Behçet disease when other therapies fail.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

31 August 2018

Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3895195

31 August 2018

Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-013-0872-4

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38129728&oldid=1760342087"